PL334899A1 - Novel 2-amino-substituted pyridines - Google Patents

Novel 2-amino-substituted pyridines

Info

Publication number
PL334899A1
PL334899A1 PL98334899A PL33489998A PL334899A1 PL 334899 A1 PL334899 A1 PL 334899A1 PL 98334899 A PL98334899 A PL 98334899A PL 33489998 A PL33489998 A PL 33489998A PL 334899 A1 PL334899 A1 PL 334899A1
Authority
PL
Poland
Prior art keywords
amino
novel
substituted pyridines
pyridines
substituted
Prior art date
Application number
PL98334899A
Inventor
Carsten Schmeck
Arndt Brandes
Michael Loegers
Gunter Schmidt
Klaus-Dieter Bremm
Hilmar Bischoff
Delf Schmidt
Joachim Schuhmacher
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PL334899A1 publication Critical patent/PL334899A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
PL98334899A 1997-02-05 1998-01-23 Novel 2-amino-substituted pyridines PL334899A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19704243A DE19704243A1 (en) 1997-02-05 1997-02-05 New 2-amino-substituted pyridines
PCT/EP1998/000362 WO1998034920A1 (en) 1997-02-05 1998-01-23 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia

Publications (1)

Publication Number Publication Date
PL334899A1 true PL334899A1 (en) 2000-03-27

Family

ID=7819326

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98334899A PL334899A1 (en) 1997-02-05 1998-01-23 Novel 2-amino-substituted pyridines

Country Status (19)

Country Link
EP (1) EP0973744A1 (en)
JP (1) JP2001510478A (en)
KR (1) KR20000070756A (en)
CN (1) CN1252057A (en)
AU (1) AU730109B2 (en)
BG (1) BG103631A (en)
BR (1) BR9807181A (en)
CA (1) CA2279636A1 (en)
CZ (1) CZ279299A3 (en)
DE (1) DE19704243A1 (en)
HU (1) HUP0001022A2 (en)
ID (1) ID24208A (en)
IL (1) IL131127A0 (en)
NO (1) NO993738L (en)
NZ (1) NZ337011A (en)
PL (1) PL334899A1 (en)
SK (1) SK104099A3 (en)
TR (1) TR199901857T2 (en)
WO (1) WO1998034920A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19845402B4 (en) * 1998-10-02 2005-04-07 Aventis Pharma Deutschland Gmbh Heterocyclic substituted propanolamine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
MXPA03011784A (en) 2001-06-22 2004-04-02 Pfizer Prod Inc Pharmaceutical compositions of dispersions of drugs and neutral polymers.
KR100759635B1 (en) 2001-06-22 2007-09-17 화이자 프로덕츠 인코포레이티드 Pharmaceutical compositions of adsorbates of amorphous drug
DE60320940D1 (en) 2002-02-01 2008-06-26 Pfizer Prod Inc PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DISPERSIONS OF ACTIVE SUBSTANCES AND LIPOPHILIC MICROPHASE-BASED MATERIALS
BRPI0408442A (en) 2003-03-17 2006-04-04 Japan Tobacco Inc method for increasing the oral bioavailability of s- [2 - ([[1- (2-ethylbutyl) cyclohexyl] carbonyl] amino) phenyl] 2-methylpropanothioate
JP2007501218A (en) 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク Pharmaceutical composition of adsorbate of amorphous drug and lipophilic microphase-forming substance
CL2004001884A1 (en) 2003-08-04 2005-06-03 Pfizer Prod Inc DRYING PROCEDURE FOR SPRAYING FOR THE FORMATION OF SOLID DISPERSIONS AMORPHES OF A PHARMACO AND POLYMERS.
KR20070087197A (en) 2003-09-26 2007-08-27 니뽄 다바코 산교 가부시키가이샤 Residual Lipoprotein Production Inhibition Method
DOP2005000123A (en) * 2004-07-02 2011-07-15 Merck Sharp & Dohme CETP INHIBITORS
WO2006032987A1 (en) * 2004-09-23 2006-03-30 Pfizer Products Inc. Indoline compounds and their use in the treatment of arteriosclerosis
EP1844078B1 (en) 2005-02-03 2016-09-28 Bend Research, Inc Pharmaceutical compositions with enhanced performance
US20100113473A1 (en) 2008-10-30 2010-05-06 Player Mark R Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) * 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis

Also Published As

Publication number Publication date
KR20000070756A (en) 2000-11-25
NO993738L (en) 1999-09-17
EP0973744A1 (en) 2000-01-26
CA2279636A1 (en) 1998-08-13
BR9807181A (en) 2000-01-25
SK104099A3 (en) 2000-01-18
DE19704243A1 (en) 1998-08-06
AU6212398A (en) 1998-08-26
IL131127A0 (en) 2001-01-28
ID24208A (en) 2000-07-13
BG103631A (en) 2000-11-30
NO993738D0 (en) 1999-08-02
TR199901857T2 (en) 1999-10-21
NZ337011A (en) 2001-04-27
CZ279299A3 (en) 1999-11-17
JP2001510478A (en) 2001-07-31
AU730109B2 (en) 2001-02-22
CN1252057A (en) 2000-05-03
WO1998034920A1 (en) 1998-08-13
HUP0001022A2 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
HRP970330B1 (en) Cycloalkano pyridines
IL132033A0 (en) Nicotinamide derivatives
SG46782A1 (en) Bicyclic-fused pyridines
IL133904A0 (en) Pyridine derivatives
PL338259A1 (en) Novel spiroazabicyclic heterocyclic compounds
IL132170A0 (en) Novel heterocyclic compounds
IL135343A0 (en) Novel aryloxy-alkyl-dialkylamines
SI1036083T1 (en) Novel 9a-azalides
GB9711124D0 (en) Novel cyanoguanidines
GB9711119D0 (en) Novel cyanoguanidines
EP0986389A4 (en) Novel process
ZA981920B (en) Novel heterocyclic compounds
GB9711122D0 (en) Novel cyanoguanidines
GB9711127D0 (en) Novel cyanoguanidines
GB9700690D0 (en) Novel process
GB9706923D0 (en) Pyridine derivatives
ZA985543B (en) Novel methods
ZA985448B (en) Novel heterocyclic compounds
PL336639A1 (en) Novel heterocyclic compounds
PL322698A1 (en) Novel compound - furane derivative
PL318601A1 (en) Novel 5-arylidene-4-oxo-2-imidazpglycines
ZA9811565B (en) Novel pyridine and pyrimidine derivatives
GB9712208D0 (en) Novel spite
ZA989529B (en) Bicyclic pyridines
IL155605A0 (en) Substituted pyridines as anti-hyperlipoproteinemic agents